Tag: generative ai in drug discovery market size

  • How the Generative Artificial Intelligence (AI) In Drug Discovery Market is Positioned for Growth: Trends, Market Size, and Future Opportunities (2025-2034)

    How the Generative Artificial Intelligence (AI) In Drug Discovery Market is Positioned for Growth: Trends, Market Size, and Future Opportunities (2025-2034)

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    Which Primary Drivers Are Supporting the Continued Market Growth of theGenerative Artificial Intelligence (AI) In Drug Discovery Market?

    The increment in clinical trials is believed to accelerate the expansion of generative AI in the drug discovery sector. Clinical trials, which use human participants to examine the safety and efficiency of novel medical procedures or treatments, aim to collect scientific evidence on their appropriateness for human application. The surge in clinical trial numbers is primarily due to progress in medical research, escalation of disease prevalence, regulatory alterations, the international spread of clinical research, patient support and awareness, industry rivalry, technological innovation, and financial support opportunities. The data from clinical trials aids generative AI models, which fast-tracks the discovery of drugs via the prediction of interactions and the design of compounds. This collaboration is instrumental in establishing personalized medicine, enhancing effective treatment, improving patient results, and transforming the pharmaceutical sector. For example, as per ClinicalTrials.gov, an American clinical trial registry, 477,234 clinical trials were registered globally by the terminus of 2023, a rise from the 437,512 trials recorded in 2022. Thus, the surge in clinical trials is pushing the growth of generative AI in the drug discovery sector.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16067&type=smp

    #What Growth Opportunities Will Drive the Generative Artificial Intelligence (AI) In Drug Discovery Market’s CAGR Through 2034?

    The market size for generative artificial intelligence (AI) used in drug discovery has seen a massive expansion in recent years. The market, valued at $0.19 billion in 2024, is projected to climb to $0.25 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 30.9%. Factors such as the increased prevalence of chronic diseases, progress in drug discovery and clinical trials that involve AI, burgeoning biotech industries, and enhanced government backing are accountable for the growth witnessed in the historic period.

    The market size for generative artificial intelligence (AI) in drug discovery is predicted to expand exponentially in the coming years. The market is set to soar to $0.74 billion in 2029, growing at a compound annual growth rate (CAGR) of 30.6%. The anticipated growth during this forecast period is associated with the growing need for affordable drug discovery sparking generative AI adoption, increased partnerships between market players, enhancing computational power, the amalgamation of generative AI with other novel technologies, and swift drug development. The primary trends within the forecast period encompass progressing technologies, the fusion of generative AI with experimental biology, increased use of high-throughput screening to expedite drug discovery processes, the creation of AI-driven platforms for drug repurposing, and a rise in the uptake of cloud-based AI solutions to bolster collaborative drug discovery initiatives.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16067

    How Are Consumer Market Innovations Shaping the Current and Future Landscape of theGenerative Artificial Intelligence (AI) In Drug Discovery Market?

    Leading firms in the generative AI sector of drug discovery are advancing in the creation of AI-powered instruments that hasten the drug discovery procedures. These AI tools speed up drug creation by making drug discovery, designing, and clinical trials more efficient with the use of predictive analytics and machine learning. This enhances efficiency in areas such as target identification and compound screening, including AI-based virtual screenings, preclinical development, regulatory adherence, and manufacturing processes. For example, in May 2023, Google Cloud (an American cloud computing service by Google) launched two groundbreaking AI-based solutions. These solutions – the Target and Lead Identification Suite and the Multiomics Suite – are aimed at enhancing drug discovery and precision medicine in biotech, pharmaceutical, and public sector organizations. The Target and Lead Identification Suite assists researchers in comprehending amino acid functions and predicting protein structures, while the Multiomics Suite accelerates the understanding and analysis of genomic data, thus simplifying the creation of personalized treatments.

    Who Are the Key Market Players Influencing the Growth of the Corn and Generative Artificial Intelligence (AI) In Drug Discovery Industry?

    Major companies operating in the generative artificial intelligence (AI) in drug discovery market are Bayer AG, NVIDIA Corporation, Merck KGaA, IBM Research, Schrödinger Inc., Valo Health, BenevolentAI, XtalPi Inc., Insilico Medicine Inc., Recursion Pharmaceuticals Inc., Exscientia, Atomwise Inc., InveniAI LLC, Healx, Aitia, Cloud Pharmaceuticals Inc., Optibrium, Aiforia, BioSymetrics Inc., Collaborations Pharmaceuticals Inc., MAbSilico, Reverie Labs, Standigm Inc., DeepMatter Group Limited, Variational AI Inc

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/generative-artificial-intelligence-ai-in-drug-discovery-global-market-report

    Which Key Market Segments Comprise the Generative Artificial Intelligence (AI) In Drug Discovery Market and Drive Its Revenue Growth?

    The generative artificial intelligence (AI) in drug discovery market covered in this report is segmented –

    1) By Type: Small Molecule, Large Molecule

    2) By Technology: Deep Learning, Machine Learning, Reinforcement Learning, Molecular Docking, Quantum Computing

    3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutions, Contract Research Organizations (CROs), Other End-Users

    Subsegments:

    1) By Small Molecule: Drug Design And Optimization, Lead Discovery And Identification, Toxicology Prediction, Molecular Property Prediction, ADMET (Absorption, Distribution, Metabolism, Excretion, And Toxicity) Prediction

    2) By Large Molecule: Protein Structure Prediction, Antibody Design, Biologics Optimization, Peptide Design, Biopharmaceutical Discovery And Optimization

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=16067&type=smp

    Which Regions Are Emerging as Leaders in the Generative Artificial Intelligence (AI) In Drug Discovery Market?

    North America was the largest region in the generative AI in drug discovery market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generative artificial intelligence (AI) in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Reports Similar to the Global Generative Artificial Intelligence (AI) In Drug Discovery Market 2025, By The Business Research Company:

    Automotive Artificial Intelligence Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/automotive-artificial-intelligence-global-market-report

    Generative Artificial Intelligence In Development And Operations (DevOps) Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/generative-artificial-intelligence-in-development-and-operations-devops-global-market-report

    Artificial Intelligence in Healthcare Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Key Drivers and Opportunities in the Generative Artificial Intelligence (AI) In Drug Discovery Market: Insights into Trends and Growth

    Key Drivers and Opportunities in the Generative Artificial Intelligence (AI) In Drug Discovery Market: Insights into Trends and Growth

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What Long-Term Growth Rate is Expected for the Generative Artificial Intelligence (AI) In Drug Discovery Market Between 2025 and 2034?

    The market size for generative AI in drug discovery has experienced significant growth recently. It is projected to expand from a value of $0.19 billion in 2024 to $0.25 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 30.9%. This considerable growth during the historic period is due to factors such as a rise in chronic diseases, the advancement of new drug discoveries and clinical trials that integrate AI, the expansion of biotech industries, and increased support from government entities.

    The market size of generative artificial intelligence (AI) in drug discovery is projected to undergo significant expansion in the coming years, predicted to reach a value of $0.74 billion in 2029 with a compound annual growth rate (CAGR) of 30.6%. The anticipated growth during the forecast period is due to factors such as the increasing demand for cost-efficient drug discovery, enhanced collaboration among market participants, the rise in computational capabilities, the convergence of generative AI with other upcoming technologies, and speedy drug development. Key trends during the forecast period comprise of breakthrough technologies, the amalgamation of generative AI with experimental biology, swift and efficient screening processes for accelerated drug discovery pipelines, the emergence of AI-powered platforms for repurposing drugs, and a surge in the use of cloud-based AI services for collective efforts in drug discovery.

    Which Factors Are Enhancing the Growth of the Generative Artificial Intelligence (AI) In Drug Discovery Market?

    The surge in clinical trials is anticipated to stimulate the expansion of generative AI in the domain of drug discovery. Clinical trials necessitate the participation of human volunteers, evaluating the security and efficiency of fresh medical treatments or procedures with the objective of accumulating scientific evidence regarding their appropriateness for human utilization. The upsurge in the quantity of clinical trials is chiefly due to advancements in healthcare research, heightened disease burden, regulatory modifications, worldwide consolidation of clinical research, advocacies and awareness for patients, industrial rivalry, progression in technology, and funding prospects. Data from clinical trials nourish generative AI models, accelerating drug discovery by predicting interactions and concocting compounds. This cooperative relationship enables individualized medicine, enhances the effectiveness of treatment, betters patient results, and instigates a transformation in the pharmaceutical scenario. For example, as stated by ClinicalTrials.gov, an American clinical trial records repository, by the close of 2023, the global registration of clinical trials was 477,234, which was a surge from the 437,512 trials which were registered in 2022. Consequently, the escalation in the quantity of clinical trials is propelling the expansion of generative AI in the drug discovery market.

    Get Your Free Sample of the Global Generative Artificial Intelligence (AI) In Drug Discovery Market Report Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16067&type=smp

    What Are the Key Firms That Are Driving Transformation in the Generative Artificial Intelligence (AI) In Drug Discovery Market?

    Major companies operating in the generative artificial intelligence (AI) in drug discovery market are:

    • TUI AG_x000D_

    • China CYTS Tours Holding Co. Ltd._x000D_

    • Abercrombie & Kent Group_x000D_

    • Intrepid Travel Pty Ltd._x000D_

    • Backroads Inc._x000D_

    What Current Trends in the Generative Artificial Intelligence (AI) In Drug Discovery Market Should Industry Players Pay Attention To?

    Top establishments operating in the generative AI field for drug discovery are creating superior AI-induced tools to expedite the process of drug discovery. Tools powered by AI quicken the drug development process by enhancing the discovery, design, and clinical trials of drugs through predictive analysis and machine learning techniques. They increase the productivity in target recognition and compound examination, such as AI-based virtual screening, preclinical development, managing regulatory compliance, and manufacturing processes. For example, in May 2023, Google Cloud, a cloud computing service from the USA offered by Google, launched two groundbreaking AI-directed solutions. These solutions, the Target and Lead Identification Suite as well as the Multiomics Suite, are planned to enhance drug discovery and precision medicine within biotech, pharmaceutical, and government field organizations. The Target and Lead Identification Suite aids researchers in understanding the roles of amino acids and predicting protein structures, whereas the Multiomics Suite allows faster analysis and comprehension of genomic data, making the development of individualized treatments simpler.

    Get Instant Access to the Global Generative Artificial Intelligence (AI) In Drug Discovery Market Report with Swift Delivery!

    https://www.thebusinessresearchcompany.com/report/generative-artificial-intelligence-ai-in-drug-discovery-global-market-report

    Which Segments Play a Crucial Role in the Expansion of the Generative Artificial Intelligence (AI) In Drug Discovery Market?

    The generative artificial intelligence (AI) in drug discovery market covered in this report is segmented –

    1) By Type: Small Molecule, Large Molecule

    2) By Technology: Deep Learning, Machine Learning, Reinforcement Learning, Molecular Docking, Quantum Computing

    3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutions, Contract Research Organizations (CROs), Other End-Users

    Subsegments:

    1) By Small Molecule: Drug Design And Optimization, Lead Discovery And Identification, Toxicology Prediction, Molecular Property Prediction, ADMET (Absorption, Distribution, Metabolism, Excretion, And Toxicity) Prediction

    2) By Large Molecule: Protein Structure Prediction, Antibody Design, Biologics Optimization, Peptide Design, Biopharmaceutical Discovery And Optimization

    What Regions Are Driving Expansion in the Generative Artificial Intelligence (AI) In Drug Discovery Market?

    North America was the largest region in the generative AI in drug discovery market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generative artificial intelligence (AI) in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Key Parameters Define the Generative Artificial Intelligence (AI) In Drug Discovery Market’s Scope?

    Generative AI in drug discovery involves using advanced machine learning, especially generative models, to create and identify new pharmaceutical compounds. These AI systems analyze extensive data, including chemical properties, biological activity, and existing drug information to predict and generate novel molecules with potential therapeutic benefits. The primary aim of generative AI in drug discovery is to accelerate the creation and identification of novel pharmaceutical compounds with potential therapeutic effects, optimizing the drug development process by leveraging extensive data to predict and generate new molecules efficiently.

    Browse Through More Similar Reports By The Business Research Company:

    Automotive Artificial Intelligence Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/automotive-artificial-intelligence-global-market-report

    Generative Artificial Intelligence In Development And Operations (DevOps) Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/generative-artificial-intelligence-in-development-and-operations-devops-global-market-report

    Artificial Intelligence in Healthcare Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: